Related Experiment Videos
[Toxicity of an original antiemetic preparation dimetpramid]
Farmakologiia I Toksikologiia
|November 1, 1985
Abstract:
A new original drug dimetpramid injected per os into mice and rats exhibits moderate toxicity, exerts a weak irritating action on the mucous membranes. The drug is capable of penetrating via the unaffected skin, producing systemic effects. With all routes of administration the drug may have a moderate inhibitory action on ovarian function and the manifestation of the hypotensive effect.
Insights
The new drug dimetpramid shows moderate toxicity and mild irritation in animal studies. It can be absorbed through the skin, potentially affecting ovarian function and blood pressure.
Area of Science:
- Pharmacology
- Toxicology
Background:
- Investigating the toxicological profile and systemic effects of novel pharmaceutical compounds is crucial for drug development.
- Understanding drug absorption routes and potential physiological impacts informs safety assessments.
Purpose of the Study:
- To evaluate the toxicity and systemic effects of the novel drug dimetpramid.
- To assess the potential for skin penetration and its impact on physiological functions.
Main Methods:
- Oral administration of dimetpramid to mice and rats.
- Observation of toxicological effects, including irritation and systemic impacts.
- Assessment of drug absorption through intact skin.
Main Results:
- Dimetpramid demonstrated moderate toxicity and weak mucous membrane irritation.
- The drug was absorbed through unaffected skin, leading to systemic effects.
- Moderate inhibition of ovarian function and a hypotensive effect were observed across administration routes.
Conclusions:
- Dimetpramid exhibits a toxicological profile with potential for systemic effects via multiple administration routes.
- The drug's ability to penetrate skin and affect ovarian function and blood pressure warrants further investigation.